The study, sponsored by the Icahn School of Medicine at Mount Sinai, explores a novel cognitive reappraisal training approach for treating Borderline Personality Disorder (BPD), a condition affecting 2% to 5.9% of the population with limited effective treatment options. Given the high prevalence and chronicity of BPD, successful outcomes could position this intervention as a valuable addition to the treatment landscape, potentially addressing unmet needs in a market characterized by a lack of approved pharmacological therapies. The results may enhance the competitive positioning of the sponsor and collaborators, including the National Institute of Mental Health (NIMH), in the field of psychiatric interventions. Diligence should focus on the scalability of the intervention and potential integration into existing treatment paradigms.